Target intelligence / Profile preview

Troponin T1, skeletal, slow (TNNT1)

Target
TNNT1
Molecular classification
Troponin complex, Structural protein, Muscle protein
01

Overview

Troponin T1, skeletal, slow (TNNT1) is a critical protein component of the troponin complex located on the thin filaments of slow-twitch (Type I) skeletal muscle fibers. It serves as the tropomyosin-binding subunit, anchoring the troponin complex to the muscle filament and playing a pivotal role in the calcium-mediated regulation of muscle contraction. When calcium binds to troponin C, TNNT1 facilitates the conformational shift of tropomyosin, exposing myosin-binding sites on actin and allowing for cross-bridge cycling. Mutations in the TNNT1 gene are primarily associated with Nemaline Myopathy type 5, a severe autosomal recessive muscle disorder characterized by progressive muscle weakness and respiratory insufficiency. While most current skeletal muscle troponin activators like Reldesemtiv target the fast isoform (TNNT3), TNNT1 is an emerging target for gene replacement therapies and small molecules aimed at restoring muscle function in slow-twitch fibers. Understanding TNNT1 is essential for developing treatments for neuromuscular diseases that specifically affect postural and endurance-based muscle groups.

Other names
Slow skeletal muscle troponin TsTnTTroponin T type 1STNTTNT1
02

Mechanism of action

Skeletal muscle troponin activators (SSTAs) bind to the fast skeletal troponin complex, but research into slow skeletal troponin (TNNT1) modulation is primarily focused on gene replacement therapy and stabilizing the troponin-tropomyosin complex to enhance calcium sensitivity and force production in slow-twitch fibers.

03

Biological functions

Muscle contractionCalcium-dependent regulation of striated muscle contractionActin-myosin interaction regulationTroponin complex assembly
04

Disease associations

Nemaline myopathy type 5 (Amish nemaline myopathy)Distal arthrogryposisSkeletal muscle weakness
05

Safety considerations

Off-target effects on cardiac troponin (potential cardiotoxicity)Muscle fatigue due to prolonged contractionNeuromuscular junction overstimulation
06

Interacting drugs

Reldesemtiv (CK-2127107)

1 more in the full profile.

07

Biomarkers

Serum slow skeletal troponin T (sTnT) levelsTNNT1 gene mutations (for Nemaline Myopathy diagnosis)

Beyond the preview

Go deeper on Troponin T1, skeletal, slow (TNNT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troponin T1, skeletal, slow (TNNT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call